[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Ukko Inc\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100619791",false,"NCT07349212","UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies","A First-in-Human, Ascending Dose, Open-label, Multicenter Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of UKK-0018 in Peanut Allergic Individuals","UKK-0018","Inclusion Criteria:\n\n* Adults 18-55 years old\n* documented history of physician-diagnosed peanut allergy\n* positive skin prick test (SPT)\n* screening DBPCFC peanut protein\n* contraception use should be consistent with local regulations\n* capable of providing signed written informed consent\n\nExclusion Criteria:\n\n* asthma based on NHLBI\n* uncontrolled cardiovascular disease\n* chronic disease history\n* exacerbation of dermatological conditions\n* life threatening episodes of anaphylaxis\n* active infections\n* poor physical or blood chemistry\n* immunodeficiency, bleeding disorders, malignancies\n* hypersensitivities to epinephrine, inactive ingredients in therapy\n* pregnant or breast feeding","ALL","18 Years","55 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE1","PHASE2","This study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies. The treatment is given by injection and is designed to train the immune system to tolerate peanut exposure over time.",[28,29],"Peanut-Induced Anaphylaxis","Peanut Allergy",[31,32],"peanut","peanut allergy","RECRUITING","2026-06-22",{"date":36,"type":37},"2026-06-25","ACTUAL",{"date":39,"type":37},"2026-02-18",{"date":41,"type":21},"2027-11-01",{"name":43,"class":44},"Ukko Inc","INDUSTRY",5,""]